Northwire Canada EditionTuesday, July 28, 2026
Sign inSubscribe
Northwire
⌕
MNRG 0.080 −11.1% KFR 1.31 +0.8% AUMN 0.275 +0.0% GLB 0.250 +0.0% BHS 0.045 −10.0% EGR 0.025 +0.0% RIO 2.59 −4.1% GEN 0.070 +0.0% MAI 4.39 −2.0% RYR 0.175 +0.0% SCD 0.170 +1.5% SRC 1.75 −2.8% FOXT 0.155 +0.0% TG 0.180 −2.7% NOBL 0.100 −4.8% MGG 0.300 +0.0% MNRG 0.080 −11.1% KFR 1.31 +0.8% AUMN 0.275 +0.0% GLB 0.250 +0.0% BHS 0.045 −10.0% EGR 0.025 +0.0% RIO 2.59 −4.1% GEN 0.070 +0.0% MAI 4.39 −2.0% RYR 0.175 +0.0% SCD 0.170 +1.5% SRC 1.75 −2.8% FOXT 0.155 +0.0% TG 0.180 −2.7% NOBL 0.100 −4.8% MGG 0.300 +0.0%
Other

AIML Subsidiary NeuralCloud Solutions and Toronto Heart Centre Launch a Pilot Program to Test AI-Powered Holter ECG Reporting

By The Northwire Desk — AI Analysis Oct 07, 2025 · 07:00 AIML · 0.05 AI-ML Innovations Inc.
AIML · Price

Executive Summary

  • AI/ML Innovations Inc. (AIML) announced a collaborative pilot study with the Toronto Heart Centre to evaluate its CardioYield™ ECG visualization and reporting platform.
  • The study will compare Holter ECG workflow efficiency, report turnaround time, and analysis quality against current industry‑standard software.
  • Positive statements from senior executives highlight the potential for significant time savings, increased technician throughput, and improved diagnostic reliability.

Key Details

  • Partnership: AIML’s wholly owned subsidiary, NeuralCloud Solutions Inc., will work with the Toronto Heart Centre (affiliated with St. Michael's Hospital) on the pilot.
  • Product Tested: CardioYield™ – a visualization and reporting interface powered by MaxYield™, AIML’s AI‑driven ECG signal‑processing platform.
  • Study Objectives:
  • Measure technician efficiency gains and reduction in report completion time.
  • Assess throughput improvements (more reports per technician).
  • Evaluate analysis quality, including automated baseline wander removal, artifact suppression, and beat‑level PQRST labeling with interval calculations (QT, PR, RR, ST).
  • Potential Benefits: Streamlined reporting workflow, reduced repetitive corrections, decreased analyst fatigue, and higher diagnostic reliability.
  • Management Commentary:
  • Dr. Chi Ming Chow (Toronto Heart Centre) emphasized the need for faster Holter reporting and the promise of CardioYield™.
  • Esmat Naikyar (CPO, AIML) noted the study will quantify real‑world efficiency gains.
  • Paul Duffy (CEO, AIML) described the pilot as a milestone for applying AI analytics in clinical practice.
  • Contact Information: Blake Fallis – (778) 405‑0882; [email protected]

Notable Quotes

“Holter reporting remains a time‑intensive process, and innovations like CardioYield™ offer the potential to improve both speed and diagnostic reliability…” – Dr. Chi Ming Chow

“This study is an opportunity to demonstrate measurable value in real‑world clinical practice.” – Esmat Naikyar

“We’re eager to validate that impact in collaboration with one of Canada’s most respected cardiology centres.” – Paul Duffy

Read the original news release →

More from AI-ML Innovations Inc.

Jun 23, 2026 · 07:00

AI cardiac analytics pilot-stage company secures patent and settles debt via equity issuance.

Financings May 11, 2026 · 22:20

AI/ML Innovations Secures Funding Amidst Dilutive Debt Settlements

Financings Apr 24, 2026 · 19:52

AIML Settles Debt with Equity as Liquidity Concerns Mount Amidst Unmonetized Pilots

Financings Apr 17, 2026 · 20:00

AI/ML Innovations Settles Debt with Equity Amidst Stagnant Valuation

Financings Mar 27, 2026 · 17:00

AI/ML Innovations Inc. Announces Closing of First Tranche of Private Placement to Raise $950,000

Financings Mar 12, 2026 · 19:30

AI/ML Innovations Inc. Announces Proposed Private Placement of Convertible Debentures

Financings